TY - JOUR AU - Garraway, L. A. PY - 2013 DA - 2013// TI - Genomics-driven oncology: framework for an emerging paradigm JO - J Clin Oncol ID - Garraway2013 ER - TY - JOUR AU - Frampton, G. M. AU - Fichtenholtz, A. AU - Otto, G. A. AU - Wang, K. AU - Downing, S. R. AU - He, J. PY - 2013 DA - 2013// TI - Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing JO - Nat Biotechnol VL - 31 UR - https://doi.org/10.1038/nbt.2696 DO - 10.1038/nbt.2696 ID - Frampton2013 ER - TY - JOUR AU - Cryan, J. B. AU - Haidar, S. AU - Ramkissoon, L. A. AU - Bi, W. L. AU - Knoff, D. S. AU - Schultz, N. PY - 2014 DA - 2014// TI - Clinical multiplexed exome sequencing distinguishes adult oligodendroglial neoplasms from astrocytic and mixed lineage gliomas JO - Oncotarget VL - 5 UR - https://doi.org/10.18632/oncotarget.2342 DO - 10.18632/oncotarget.2342 ID - Cryan2014 ER - TY - JOUR AU - Pritchard, C. C. AU - Salipante, S. J. AU - Koehler, K. AU - Smith, C. AU - Scroggins, S. AU - Wood, B. PY - 2014 DA - 2014// TI - Validation and implementation of targeted capture and sequencing for the detection of actionable mutation, copy number variation, and gene rearrangement in clinical cancer specimens JO - J Mol Diagn VL - 16 UR - https://doi.org/10.1016/j.jmoldx.2013.08.004 DO - 10.1016/j.jmoldx.2013.08.004 ID - Pritchard2014 ER - TY - JOUR AU - Cheng, D. T. AU - Mitchell, T. N. AU - Zehir, A. AU - Shah, R. H. AU - Benayed, R. AU - Syed, A. PY - 2015 DA - 2015// TI - Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology JO - J Mol Diagn VL - 17 UR - https://doi.org/10.1016/j.jmoldx.2014.12.006 DO - 10.1016/j.jmoldx.2014.12.006 ID - Cheng2015 ER - TY - JOUR AU - Wagle, N. AU - Berger, M. F. AU - Davis, M. J. AU - Blumenstiel, B. AU - Defelice, M. AU - Pochanard, P. PY - 2012 DA - 2012// TI - High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing JO - Cancer Discov VL - 2 UR - https://doi.org/10.1158/2159-8290.CD-11-0184 DO - 10.1158/2159-8290.CD-11-0184 ID - Wagle2012 ER - TY - STD TI - Sohal DPS, BI Rini, Khorana AA, Dreicer R, Abraham J, Procop GW, Saunthararajah Y, Pennell NA, Stevenson JP, Pelley R, Estfan B, Shepard D, Funchain P, Elson P, Adelstein DJ, Brian J. Bolwell prospective clinical study of precision oncology in solid tumors. JNCI J Natl Cancer Inst. 2016;108(3):djv332. doi:10.1093/jnci/djv332. ID - ref7 ER - TY - JOUR AU - Chen, K. AU - Meric-Bernstam, F. AU - Zhao, H. AU - Zhang, Q. AU - Ezzeddine, N. AU - Tang, L. Y. PY - 2015 DA - 2015// TI - Clinical actionability enhanced through deep targeted sequencing of solid tumors JO - Clin Chem VL - 61 UR - https://doi.org/10.1373/clinchem.2014.231100 DO - 10.1373/clinchem.2014.231100 ID - Chen2015 ER - TY - JOUR AU - Fisher, K. E. AU - Zhang, L. AU - Wang, J. AU - Smith, G. H. AU - Newman, S. AU - Schneider, T. M. PY - 2016 DA - 2016// TI - Clinical validation and implementation of a targeted next-generation sequencing assay to detect somatic variants in non-small cell lung, melanoma, and gastrointestinal malignancies JO - J Mol Diagn VL - 18 UR - https://doi.org/10.1016/j.jmoldx.2015.11.006 DO - 10.1016/j.jmoldx.2015.11.006 ID - Fisher2016 ER - TY - JOUR AU - Cottrell, C. E. AU - Al-Kateb, H. AU - Bredemeyer, A. J. AU - Duncavage, E. J. AU - Spencer, D. H. AU - Abel, H. J. PY - 2014 DA - 2014// TI - Validation of a next-generation sequencing assay for clinical molecular oncology JO - J Mol Diagn VL - 16 UR - https://doi.org/10.1016/j.jmoldx.2013.10.002 DO - 10.1016/j.jmoldx.2013.10.002 ID - Cottrell2014 ER - TY - STD TI - Roychowdhury S, Iyer MK, Robinson DR, Lonigro RJ, Wu YM, Cao X, et al. Personalized oncology through integrative high-throughput sequencing: a pilot study. Sci Transl Med. 2011;3(111):111ra21. doi:10.1126/scitranslmed.3003161. Epub 2011/12/03. PubMed PMID: 22133722; PubMed Central PMCID: PMC3476478. ID - ref11 ER - TY - JOUR AU - Allen, E. M. AU - Wagle, N. AU - Stojanov, P. AU - Perrin, D. L. AU - Cibulskis, K. AU - Marlow, S. PY - 2014 DA - 2014// TI - Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine JO - Nat Med VL - 20 UR - https://doi.org/10.1038/nm.3559 DO - 10.1038/nm.3559 ID - Allen2014 ER - TY - JOUR AU - Beltran, H. AU - Eng, K. AU - Mosquera, J. M. AU - Sigaras, A. AU - Romanel, A. AU - Rennert, H. PY - 2015 DA - 2015// TI - Whole-exome sequencing of metastatic cancer and biomarkers of treatment response JO - JAMA Oncol VL - 1 UR - https://doi.org/10.1001/jamaoncol.2015.1313 DO - 10.1001/jamaoncol.2015.1313 ID - Beltran2015 ER - TY - JOUR AU - Schumacher, T. N. AU - Kesmir, C. AU - Buuren, M. M. PY - 2015 DA - 2015// TI - Biomarkers in cancer immunotherapy JO - Cancer Cell VL - 27 UR - https://doi.org/10.1016/j.ccell.2014.12.004 DO - 10.1016/j.ccell.2014.12.004 ID - Schumacher2015 ER - TY - JOUR AU - Le, D. T. AU - Uram, J. N. AU - Wang, H. AU - Bartlett, B. R. AU - Kemberling, H. AU - Eyring, A. D. PY - 2015 DA - 2015// TI - PD-1 Blockade in tumors with mismatch-repair deficiency JO - N Engl J Med ID - Le2015 ER - TY - JOUR AU - Snyder, A. AU - Makarov, V. AU - Merghoub, T. AU - Yuan, J. AU - Zaretsky, J. M. AU - Desrichard, A. PY - 2014 DA - 2014// TI - Genetic basis for clinical response to CTLA-4 blockade in melanoma JO - N Engl J Med VL - 371 UR - https://doi.org/10.1056/NEJMoa1406498 DO - 10.1056/NEJMoa1406498 ID - Snyder2014 ER - TY - JOUR AU - Rizvi, N. A. AU - Hellmann, M. D. AU - Snyder, A. AU - Kvistborg, P. AU - Makarov, V. AU - Havel, J. J. PY - 2015 DA - 2015// TI - Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer JO - Science VL - 348 UR - https://doi.org/10.1126/science.aaa1348 DO - 10.1126/science.aaa1348 ID - Rizvi2015 ER - TY - JOUR AU - Allen, E. M. AU - Miao, D. AU - Schilling, B. AU - Shukla, S. A. AU - Blank, C. AU - Zimmer, L. PY - 2015 DA - 2015// TI - Genomic correlates of response to CTLA-4 blockade in metastatic melanoma JO - Science VL - 350 UR - https://doi.org/10.1126/science.aad0095 DO - 10.1126/science.aad0095 ID - Allen2015 ER - TY - STD TI - Campesato LF, Barroso-Sousa R, Jimenez L, Correa BR, Sabbaga J, Hoff PM, et al. Comprehensive cancer-gene panels can be used to estimate mutational load and predict clinical benefit to PD-1 blockade in clinical practice. Oncotarget. 2015;6(33):34221–7. doi:10.18632/oncotarget.5950. ID - ref19 ER - TY - JOUR AU - Stadler, Z. K. AU - Battaglin, F. AU - Middha, S. AU - Hechtman, J. F. AU - Tran, C. AU - Cercek, A. PY - 2016 DA - 2016// TI - Reliable detection of mismatch repair deficiency in colorectal cancers using mutational load in next-generation sequencing panels JO - J Clin Oncol ID - Stadler2016 ER - TY - JOUR AU - Meric-Bernstam, F. AU - Brusco, L. AU - Shaw, K. AU - Horombe, C. AU - Kopetz, S. AU - Davies, M. A. PY - 2015 DA - 2015// TI - Feasibility of large-scale genomic testing to facilitate enrollment onto genomically matched clinical trials JO - J Clin Oncol VL - 33 UR - https://doi.org/10.1200/JCO.2014.60.4165 DO - 10.1200/JCO.2014.60.4165 ID - Meric-Bernstam2015 ER - TY - JOUR AU - MacConaill, L. E. AU - Garcia, E. AU - Shivdasani, P. AU - Ducar, M. AU - Adusumilli, R. AU - Breneiser, M. PY - 2014 DA - 2014// TI - Prospective enterprise-level molecular genotyping of a cohort of cancer patients JO - J Mol Diagn VL - 16 UR - https://doi.org/10.1016/j.jmoldx.2014.06.004 DO - 10.1016/j.jmoldx.2014.06.004 ID - MacConaill2014 ER - TY - STD TI - Jones S, Anagnostou V, Lytle K, Parpart-Li S, Nesselbush M, Riley DR, et al. Personalized genomic analyses for cancer mutation discovery and interpretation. Sci Transl Med. 2015;7(283):283ra53. doi:10.1126/scitranslmed.aaa7161. PubMed PMID: 25877891; PubMed Central PMCID: PMC4442685. ID - ref23 ER - TY - JOUR AU - Schrader, K. A. AU - Cheng, D. T. AU - Joseph, V. AU - Prasad, M. AU - Walsh, M. AU - Zehir, A. PY - 2016 DA - 2016// TI - Germline variants in targeted tumor sequencing using matched normal DNA JO - JAMA Oncol VL - 2 UR - https://doi.org/10.1001/jamaoncol.2015.5208 DO - 10.1001/jamaoncol.2015.5208 ID - Schrader2016 ER - TY - JOUR AU - Reich, M. AU - Liefeld, T. AU - Gould, J. AU - Lerner, J. AU - Tamayo, P. AU - Mesirov, J. P. PY - 2006 DA - 2006// TI - GenePattern 2.0. JO - Nat Genet VL - 38 UR - https://doi.org/10.1038/ng0506-500 DO - 10.1038/ng0506-500 ID - Reich2006 ER - TY - JOUR AU - Cibulskis, K. AU - McKenna, A. AU - Fennell, T. AU - Banks, E. AU - DePristo, M. AU - Getz, G. PY - 2011 DA - 2011// TI - ContEst: estimating cross-contamination of human samples in next-generation sequencing data JO - Bioinformatics VL - 27 ID - Cibulskis2011 ER - TY - JOUR AU - Cibulskis, K. AU - Lawrence, M. S. AU - Carter, S. L. AU - Sivachenko, A. AU - Jaffe, D. AU - Sougnez, C. PY - 2013 DA - 2013// TI - Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples JO - Nat Biotechnol ID - Cibulskis2013 ER - TY - JOUR AU - Costello, M. AU - Pugh, T. J. AU - Fennell, T. J. AU - Stewart, C. AU - Lichtenstein, L. AU - Meldrim, J. C. PY - 2013 DA - 2013// TI - Discovery and characterization of artifactual mutations in deep coverage targeted capture sequencing data due to oxidative DNA damage during sample preparation JO - Nucleic Acids Res VL - 41 UR - https://doi.org/10.1093/nar/gks1443 DO - 10.1093/nar/gks1443 ID - Costello2013 ER - TY - JOUR AU - Ramos, A. H. AU - Lichtenstein, L. AU - Gupta, M. AU - Lawrence, M. S. AU - Pugh, T. J. AU - Saksena, G. PY - 2015 DA - 2015// TI - Oncotator: cancer variant annotation tool JO - Hum Mutat VL - 36 UR - https://doi.org/10.1002/humu.22771 DO - 10.1002/humu.22771 ID - Ramos2015 ER - TY - JOUR AU - Sherry, S. T. AU - Ward, M. H. AU - Kholodov, M. AU - Baker, J. AU - Phan, L. AU - Smigielski, E. M. PY - 2001 DA - 2001// TI - dbSNP: the NCBI database of genetic variation JO - Nucleic Acids Res VL - 29 UR - https://doi.org/10.1093/nar/29.1.308 DO - 10.1093/nar/29.1.308 ID - Sherry2001 ER - TY - JOUR AU - Genomes Project, C. AU - Abecasis, G. R. AU - Auton, A. AU - Brooks, L. D. AU - DePristo, M. A. AU - Durbin, R. M. PY - 2012 DA - 2012// TI - An integrated map of genetic variation from 1,092 human genomes JO - Nature VL - 491 UR - https://doi.org/10.1038/nature11632 DO - 10.1038/nature11632 ID - Genomes Project2012 ER - TY - STD TI - ExAC. Large-scale aggregation of human genomic data. 2016. http://exac.broadinstitute.org. UR - http://exac.broadinstitute.org ID - ref32 ER - TY - JOUR AU - Forbes, S. A. AU - Bindal, N. AU - Bamford, S. AU - Cole, C. AU - Kok, C. Y. AU - Beare, D. PY - 2011 DA - 2011// TI - COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer JO - Nucleic Acids Res VL - 39 UR - https://doi.org/10.1093/nar/gkq929 DO - 10.1093/nar/gkq929 ID - Forbes2011 ER - TY - JOUR AU - DePristo, M. A. AU - Banks, E. AU - Poplin, R. AU - Garimella, K. V. AU - Maguire, J. R. AU - Hartl, C. PY - 2011 DA - 2011// TI - A framework for variation discovery and genotyping using next-generation DNA sequencing data JO - Nat Genet VL - 43 UR - https://doi.org/10.1038/ng.806 DO - 10.1038/ng.806 ID - DePristo2011 ER - TY - JOUR AU - McKenna, A. AU - Hanna, M. AU - Banks, E. AU - Sivachenko, A. AU - Cibulskis, K. AU - Kernytsky, A. PY - 2010 DA - 2010// TI - The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data JO - Genome Res VL - 20 UR - https://doi.org/10.1101/gr.107524.110 DO - 10.1101/gr.107524.110 ID - McKenna2010 ER - TY - JOUR AU - Shukla, S. A. AU - Rooney, M. S. AU - Rajasagi, M. AU - Tiao, G. AU - Dixon, P. M. AU - Lawrence, M. S. PY - 2015 DA - 2015// TI - Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes JO - Nat Biotechnol VL - 33 UR - https://doi.org/10.1038/nbt.3344 DO - 10.1038/nbt.3344 ID - Shukla2015 ER - TY - JOUR AU - Hoof, I. AU - Peters, B. AU - Sidney, J. AU - Pedersen, L. E. AU - Sette, A. AU - Lund, O. PY - 2009 DA - 2009// TI - NetMHCpan, a method for MHC class I binding prediction beyond humans JO - Immunogenetics VL - 61 UR - https://doi.org/10.1007/s00251-008-0341-z DO - 10.1007/s00251-008-0341-z ID - Hoof2009 ER - TY - JOUR AU - Forbes, S. A. AU - Beare, D. AU - Gunasekaran, P. AU - Leung, K. AU - Bindal, N. AU - Boutselakis, H. PY - 2015 DA - 2015// TI - COSMIC: exploring the world’s knowledge of somatic mutations in human cancer JO - Nucleic Acids Res VL - 43 UR - https://doi.org/10.1093/nar/gku1075 DO - 10.1093/nar/gku1075 ID - Forbes2015 ER - TY - JOUR AU - Bustamante, C. D. AU - Burchard, E. G. AU - Vega, F. M. PY - 2011 DA - 2011// TI - Genomics for the world JO - Nature VL - 475 UR - https://doi.org/10.1038/475163a DO - 10.1038/475163a ID - Bustamante2011 ER - TY - JOUR AU - Schumacher, T. N. AU - Schreiber, R. D. PY - 2015 DA - 2015// TI - Neoantigens in cancer immunotherapy JO - Science VL - 348 UR - https://doi.org/10.1126/science.aaa4971 DO - 10.1126/science.aaa4971 ID - Schumacher2015 ER - TY - JOUR AU - Carreno, B. M. AU - Magrini, V. AU - Becker-Hapak, M. AU - Kaabinejadian, S. AU - Hundal, J. AU - Petti, A. A. PY - 2015 DA - 2015// TI - Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells JO - Science VL - 348 UR - https://doi.org/10.1126/science.aaa3828 DO - 10.1126/science.aaa3828 ID - Carreno2015 ER - TY - STD TI - Shukla SA, Rooney MS, Rajasagi M, Tiao G, Dixon PM, Lawrence M, et al. Sensitive detection of somatic mutations in class I HLA genes reveals enrichment for functional mutations in cancer. Nat Biotechnol. 2015; in press. ID - ref42 ER - TY - JOUR AU - Tumeh, P. C. AU - Harview, C. L. AU - Yearley, J. H. AU - Shintaku, I. P. AU - Taylor, E. J. AU - Robert, L. PY - 2014 DA - 2014// TI - PD-1 blockade induces responses by inhibiting adaptive immune resistance JO - Nature VL - 515 UR - https://doi.org/10.1038/nature13954 DO - 10.1038/nature13954 ID - Tumeh2014 ER - TY - JOUR AU - Rajasagi, M. AU - Shukla, S. A. AU - Fritsch, E. F. AU - Keskin, D. B. AU - DeLuca, D. AU - Carmona, E. PY - 2014 DA - 2014// TI - Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia JO - Blood VL - 124 UR - https://doi.org/10.1182/blood-2014-04-567933 DO - 10.1182/blood-2014-04-567933 ID - Rajasagi2014 ER - TY - JOUR AU - Gubin, M. M. AU - Artyomov, M. N. AU - Mardis, E. R. AU - Schreiber, R. D. PY - 2015 DA - 2015// TI - Tumor neoantigens: building a framework for personalized cancer immunotherapy JO - J Clin Invest VL - 125 UR - https://doi.org/10.1172/JCI80008 DO - 10.1172/JCI80008 ID - Gubin2015 ER - TY - JOUR AU - Yoshimura, K. AU - Minami, T. AU - Nozawa, M. AU - Kimura, T. AU - Egawa, S. AU - Fujimoto, H. PY - 2016 DA - 2016// TI - A phase 2 randomized controlled trial of personalized peptide vaccine immunotherapy with low-dose dexamethasone versus dexamethasone alone in chemotherapy-naive castration-resistant prostate cancer JO - Eur Urol ID - Yoshimura2016 ER - TY - JOUR AU - Noguchi, M. AU - Matsumoto, K. AU - Uemura, H. AU - Arai, G. AU - Eto, M. AU - Naito, S. PY - 2016 DA - 2016// TI - An open-label, randomized phase II trial of personalized peptide vaccination in patients with bladder cancer that progressed after platinum-based chemotherapy JO - Clin Cancer Res VL - 22 UR - https://doi.org/10.1158/1078-0432.CCR-15-1265 DO - 10.1158/1078-0432.CCR-15-1265 ID - Noguchi2016 ER - TY - JOUR AU - Lu, C. AU - Xie, M. AU - Wendl, M. C. AU - Wang, J. AU - McLellan, M. D. AU - Leiserson, M. D. PY - 2015 DA - 2015// TI - Patterns and functional implications of rare germline variants across 12 cancer types JO - Nat Commun. VL - 6 UR - https://doi.org/10.1038/ncomms10086 DO - 10.1038/ncomms10086 ID - Lu2015 ER - TY - JOUR AU - Mateo, J. AU - Carreira, S. AU - Sandhu, S. AU - Miranda, S. AU - Mossop, H. AU - Perez-Lopez, R. PY - 2015 DA - 2015// TI - DNA-repair defects and olaparib in metastatic prostate cancer JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMoa1506859 DO - 10.1056/NEJMoa1506859 ID - Mateo2015 ER -